| | CASMASCI | progen | BOC | 進(jìn)口現(xiàn)貨產(chǎn)品 | 胎牛血清 | 細(xì)胞培養(yǎng) | 提取試劑 | 轉(zhuǎn)染試劑 | 常規(guī)生化試劑 | ELISA試劑盒 | 抗體 | 細(xì)胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產(chǎn)品名稱:Levamisole hydrochloride
產(chǎn)品貨號:LKT L1682
產(chǎn)品規(guī)格:10 g
Description
An anti-neoplastic, immuno modulating agent which is used as an adjuvant in colon cancer therapy. It selectively induces apoptosis and growth arrest in cultured human micro-and macro vascular endothelial cells. In experimental animals, Levamisole reduces
Specifications
Cas No. 16595-80-5
Product ID L1682
Product Name Levamisole hydrochloride
Chemical Name Imidazo(2,1-b)thiazole,2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)- (8CI)
Synonym Tetramisole hydrochloride; Citarin L; Ergamisol; Spartakon
Formula Wt. 240.76
Melting Point 228-230oC
Purity ≥98%
Solubility Soluble in water.
Stability Sensitive to light.
Store Temp Ambient
References Artwohl M, Holzenbein T, Wagner L, Freudenthaler A, Waldhausl W, Baumgartner-Parzer SM, BR J. Pharmacol. 131:1577-1583 (2000). Suzuki H, Yamamoto J, Iwata Y, Matsumoto K, Iryama K. Jpn. J. Surg. 16:152-5 (1986). Eisenberg E, Shakilar G. Oral Surg. Oral Pa